NCT05887726 2023-07-27
Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors
Liaoning Cancer Hospital & Institute
Phase 2 Unknown
Clinical Trials
11 trialsNCT02752815 2022-12-05
Reduced Chemotherapy in Low Risk DLBCL
Ruijin Hospital
Phase 4 Unknown
NCT03286634 2022-09-28
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
National Hospital Organization Nagoya Medical Center
Phase 2 Recruiting
NCT04061772 2019-08-20
A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma
Zhejiang Cancer Hospital
Phase 2 Unknown
NCT02042690 2019-05-29
Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
Peking University
Phase 3 Completed
NCT02871869 2017-07-17
Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma
Xinjiang Medical University
Phase 2/3 Unknown
NCT03022123 2017-01-16
The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma
Hebei Medical University Fourth Hospital
Phase NA Unknown
NCT02987244 2016-12-08
Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma
Peking Union Medical College Hospital
Phase 1/2 Unknown
NCT00062296 2013-07-11
Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Fox Chase Cancer Center
Phase 2 Completed
NCT01148446 2010-06-22
ANZINTER3
Fondazione Italiana Linfomi - ETS
Phase 3 Completed
NCT00556127 2007-11-09
DLBCL
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie
Phase 2 Completed